Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
09/2003
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440390A Substituted diamide derivatives useful as motilin antagonists
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/02/2003US6613944 Process to produce 3-carbon amino alcohol salts
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
09/02/2003US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613729 Comprising organic counterion of sunflower seed-amidopropyl morpholine
09/02/2003US6613572 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
09/02/2003US6613458 Benzo(a)perylene derivative dopant
08/2003
08/28/2003WO2003070713A1 Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste
08/28/2003WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
08/28/2003WO2003017998B1 Platinum complexes and their use in cancer treatment
08/28/2003US20030162830 3,4-diphenyl-bicyclo(4.3.0)nonyl derivatives
08/28/2003US20030162820 Heterocyclic amides used as dipeptidyl aminopeptidase (DPIV) inhibitors, for prophylaxis of arthritis, obesity, allograft surgery, cancer, autoimmune, nervous system and skin disorders
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162793 Methods for preventing or treating cardiac arrhythmia
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030161860 Novel substituted aryl alkenoic acid heterocyclic amides
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/27/2003EP1337519A1 Process for the preparation of 1,5-disubstituated-3-amino-1,2,4-triazoles and substituted aminoguanidines as intermediate compounds
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438897A Remedial agent for anxiety neurosis or depression and piperazine derivative
08/27/2003CN1438883A Beta Secretase inhibitors
08/27/2003CN1119338C Alpha-(1-piperazinyl) ocetamido arenecarboxylic aicd derivatives as antidiabetic agents
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/26/2003US6610882 Affinity for bradykinin receptors; antithrombotics
08/26/2003US6610850 Contrast media for angiography
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610705 Process for the preparation of diaryl naphthyl methanes
08/26/2003US6610704 Antithrombotic amides
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/26/2003US6610689 Viricides
08/26/2003US6610660 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068217A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003WO2003018549A3 Bicyclic compounds as inhibitors of chemokine binding to us28
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158406 Enzyme inhibitor treating autoimmune diseases, Alzheimer's disease, atherosclerosis
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158236 Treating, e.g., an HIV infection.
08/21/2003US20030158231 Sulfonamide compounds as protease inhibitors
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030158207 N-benzylpiperazine compounds
08/21/2003US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158186 Compositions and methods for treating heart failure
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003US20030158180 Antidepressants; treating anxiety, stress, eating disorders, bipolar disorder, drug abuse and drug dependence, schizophrenic disorders, psychotic disorders, cognitive activators, obesity, emesis, rheumatoid arthritis, cancer
08/21/2003US20030158176 Quaternary ammonium compounds
08/21/2003CA2474171A1 Biphenil derivatives and their use as antiandrogenic agents
08/20/2003EP1336608A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives
08/20/2003EP1204592B1 Zeolite ssz-52
08/20/2003EP1194415B1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003CN1437589A Process for the preparation of pyrazolopyrimidin ones
08/20/2003CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds
08/19/2003US6608212 Palladium catalyzed coupling of a vinylphosphate and aryl-metal halide; preparation of such as 1-(4-(2-(pyrrolidin-n-yl)-ethoxy)phenyl)-6-methoxy-3,4-dihydronaphthalene
08/19/2003US6608196 Structurally diverse; parallel approach
08/19/2003US6608195 Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds
08/19/2003US6608100 HIV protease inhibitors based on amino acid derivatives
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608057 Compounds useful as reversible inhibitors of cathepsin S
08/19/2003US6607868 Photoresist monomers, polymers thereof, and photoresist compositions containing the same
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066613A1 N-phenyl-2-pyrimidine-amine derivatives
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066570A1 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands
08/14/2003WO2003066056A1 Method of promoting neuronal growth
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003031408A3 Tricyclic compounds useful for modulating lxr
08/14/2003WO2003024945A3 Method for producing polyphosphates of organic bases
08/14/2003US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
08/14/2003US20030153781 Increased enantioselectivity of asymmetric addition of organic zinc and aldehyde by providing ligands to perform as superior catalysts to form a predominance of secondary alcohol; efficiency
08/14/2003US20030153780 Water-soluble specialty surfactants to lower the surface tension of water to <20 dynes/cm.; reacting amines with allyl glycidyl ether, followed by reaction with a perfluoroalkyl iodide; oily surfaces; coatings for addition polymers
08/14/2003US20030153768 Efficient synthesis of ceramide-like compounds by reacting an aldehyde and an amidomethylisonitrile to form a 4-amido-2-oxazoline; suppress biosynthesis of glycosphingolipids; antitumor agents; Tays-Sach, Gaucher's
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153537 Reducing tetracycline resistance in living cells
08/14/2003US20030153510 Novel compounds inhibiting factor xa activity
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003CA2737565A1 N-phenyl-2-pyrimidine-amine derivatives